Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Shandong Weigao Group Medical Polymer Co ( (HK:1066) ) has issued an update.
Shandong Weigao Group Medical Polymer Company Limited announced its intention to repurchase H shares on the open market, a move aimed at preserving the company’s value. On February 11, 2025, the company completed its first share repurchase under the general mandate, acquiring 50,000 H shares at an average price of HKD4.62 each, totaling approximately HKD231,000. This strategic initiative reflects the company’s focus on optimizing shareholder value and market position while maintaining compliance with regulatory requirements.
More about Shandong Weigao Group Medical Polymer Co
Shandong Weigao Group Medical Polymer Company Limited is a joint-stock company headquartered in the People’s Republic of China. The company operates in the medical polymer industry, providing products related to medical devices and healthcare solutions. It is listed on the Hong Kong Stock Exchange, indicating its market focus and reach.
YTD Price Performance: 7.47%
Average Trading Volume: 700
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $2.69B
For an in-depth examination of 1066 stock, go to TipRanks’ Stock Analysis page.
